RWD9 Real-World Relative Dose Intensity in Patients With Advanced or Metastatic Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors in Sweden
Abstract
Authors
L Siljander A Holmen Møller A Toft Hornemann
L Siljander A Holmen Møller A Toft Hornemann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now